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Objective: To evaluate the cytotoxic and antibacterial effect of Bixa orellana L.
(B. orellana) (achiote) methanol extract against Streptococcus mutans (ATCC 25175)
(S. mutans) and Streptococcus sanguinis (ATCC 10556) (S. sanguinis).
Methods: Two methanol extracts of B. orellana were prepared in vitro, from the seeds
and leaves. The antibacterial activity of extracts against S. mutans and S. sanguinis was
evaluated using the cup-plate agar diffusion method. The minimum inhibitory concen-
tration (MIC) was determined using the microdilution method and the cytotoxic activity
was determinated by using the cell line MDCK.
Results: A stronger antibacterial effect was observed with the leaves methanolic extract
with an inhibition zone of (19.97 ± 1.31) mm against S. mutans and (19.97 ± 1.26) mm
against S. sanguinis. The methanolic extract of the seeds had an activity of (15.11 ± 1.03)
mm and (16.15 ± 2.15) mm against S. mutans and S. sanguinis, respectively. The MIC of
the leaf and the seed extracts against S. sanguinis was 62.5 and 125 mg/mL, respectively,
and the MIC of the leaf extract against S. mutans was 62.5 mg/mL, and for the seed extract
it was 31.25 mg/mL. The 50% cytotoxic concentration was 366.45 and 325.05 mg/mL for
the leaves and seeds extracts, respectively.
Conclusions: The experimental ﬁndings demonstrated the antibacterial effect of the
methanolic extract of B. orellana (achiote) on S. mutans and S. sanguinis. The extract of
this plant is cytotoxic at high concentrations.1. Introduction
The Peruvian ﬂora has an immense variety of species, which is
famous for its colorant properties as well as its medicinal values.
However, there are a lot of plants that have not been studied, and
their phytotherapeutic values are not fully understood.
Bixa orellana (B. orellana), also known as achiote or annatto,
is an American plant widely used in Peru as nourishment,seasoning, as well as a colorant in the cosmetic and paint in-
dustry [1–3]. The achiote is frequently used in the Peruvian
Amazonia as a preparation, extracted from the B. orellana
leaves, for snake bites treatment, as a food digestive and for
cough treatment [2]. B. orellana is recognized for its medicinal
applications as an antioxidant, analgesic, wound healer,
hemostatic and diuretic among others [3–5]. Apart from its
antibacterial properties that have been postulated for treatment
in certain gastrointestinal and pulmonary diseases [6,7],
B. orellana is also commonly used by urologists for prostate
cancer prevention [4,8].
The main objective of the study is to evaluate the cytotoxic
and antibacterial effects of the B. orellana methanolic extract
on the bacterial strains of Streptococcus mutans (ATCC 25175)
(S. mutans) and Streptococcus sanguinis (ATCC 10556)
(S. sanguinis) as potential applications in the odontology ﬁeld.. This is an open access article under the CC BY-
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2.1. Plant material and extracts
B. orellana was purchased from natural stores and the six of
them had sanitary registration. Seeds and leaves were chopped
and soaked in absolute methanol (1:2, w/v), and stored without
sunlinght for 10 days at room temperature. The mixtures were
ﬁltered through a Whatman No. 4 ﬁlter paper, and the ﬁltrates
were evaporated at 50 C [9]. All extracts were stored at 4 C
until used.
2.2. Bacteria strain
Strains of S. mutans and S. sanguinis were used (Genlab del
Peru S.A.C., Peru). The cultivation medium was brain heart
infusion (BHI) agar (Oxoid, Hampshire, UK). Cultures were
grown anaerobically for 72 h at 37 C. For antibacterial activity
assay, three or four isolated colonies were inoculated in 3 mL of
BHI broth and incubated under anaerobic condition for 72 h at
37 C. The cultures were later diluted with fresh medium to
approximate density of 0.5 McFarland standard, which repre-
sents an estimated concentration of 1.5 × 108 CFU/mL.
The McFarland standard was prepared by inoculating col-
onies of the bacterial test strain in sterile saline and adjusting the
cell density to the concentration speciﬁed before [10].
2.3. Antibacterial screening of the methanolic extracts
2.3.1. Determination of antibacterial activity
To determinate the antibacterial activity of the studied ex-
tracts, the cup-plate agar diffusion method was used [11]. BHI
agar was autoclaved for 15 min at 121 C and cooled to about
55 C. The medium was then inoculated with the prepared
bacterial suspension, mixed gently and ﬁnally poured into
sterile Petri dishes. Sugar tubes containing molten agar
(10 mL) were sterilized and cooled to about 40–42 C. The
tubes were then inoculated with 0.1 mL of the appropriate
culture suspension of bacteria. These agar plates were
incubated under sterile condition for 8 h at room temperature.
Three wells per plate of 6 mm in diameter and 4 mm in depth
were made with a sterile cork borer, preserving a distance of
3 cm between them. The wells were ﬁlled with 100 mL of the
corresponding methanolic extract. The chlorhexidine (0.12%)
was used as positive control [12]. The Petri dishes were
incubated under the same growth conditions mentioned above.
At the end of the period, the inhibition zones formed were
measured in millimeters using a vernier. The inhibition zones
with less than 12 mm in diameter were not considered for the
antibacterial activity analysis. For each extract, 12 replicates
were assayed.
2.3.2. Determination of minimum inhibitory
concentration (MIC)
The MIC was determined using the microdilution method as
described by Jayaraman et al. [13] and Sader et al. [14]. Serial
two-fold dilutions of all the extracts were prepared with sterile
saline in a 96-well microtiter plate, obtaining a concentration
range from 500 to 15.62 mg/mL. Then, 5 mL of S. mutans or
S. sanguinis suspension (optical density at 550 nm = 0.6) were
added to the wells containing the dilutions. Each dose wasassayed in quadruplicate. Uninoculated wells containing sterile
saline or saline and extract were used as controls. After incu-
bation under anaerobic condition for 72 h at 37 C, the samples
were observed and MIC was recorded as the lowest concentra-
tion of each plant extract that inhibited the bacterial growth as
detected by the absence of visual turbidity.
2.4. Cytotoxicity assay of B. orellana
2.4.1. Cell lines
MDCK cells were obtained from American Type Culture
Collection, USA. The cells were grown in minimum essential
medium with Earle's salts (Gibco BRL, Grand Island, NY)
supplemented with 10% fetal bovine serum, 25 mg/L gentamicin
and 200 mmol/L L-glutamine (growth medium). The cells were
maintained in minimum essential medium with 1% fetal bovine
serum, 25 mg/L gentamicin and 200 mmol/L L-glutamine
(maintenance medium). All cells were cultured at 37 C in a
humidiﬁed atmosphere with 5% CO2-95% air.
2.4.2. Cytotoxicity assay
Cytotoxicity of B. orellana seeds and leaves extract was
assessed using an assay based on the color change subsequent to
the reduction of MTT by mitochondrial enzymes [15–17]. The
assays were performed using MDCK cells at 1 × 104 cells/well
in 200 mL of medium which were cultured in 96-well plates and
incubated at 37 C in a humidiﬁed atmosphere with 5% CO2-
95% air. When cell cultures were conﬂuent, the culture medium
was removed from the wells, which were replenished with
0.2 mL of the maintenance medium containing B. orellana
extract prepared by dilution. B. orellana concentrations had a
range from 0 to 1 000 mg/mL. Each dose was assayed in
quadruplicate. The wells with 0.2 mL maintenance medium but
without B. orellana extract were used as cell controls. All
cultures were incubated at 37 C for 6 days. Cell morphology
was inspected daily for alterations. The 50% cytotoxic
concentration (CC50) is deﬁned as the concentration of
compound that reduces the viability of mock-infected cells by
50%. This index is commonly estimated by MTT assay. In our
study, 20 mL of MTT stock solution (3 mg/mL in phosphate-
buffered saline) was added to each well. After 3 h of incubation
under culture conditions, the medium was carefully removed and
formazan crystals were solubilized by adding 200 mL dimethyl
sulfoxide. Finally, cell viabilitywas expressed as the percentage of
the absorbance value determined for the control cultures. Absor-
bance (A570 nm)wasmeasured in anELISA reader. CC50was then
determined using Pharm/PCS software [18]. To conﬁrm MTT
results, the monolayers were also observed microscopically to
estimate the cytopathic effect (i.e. rounding and other marked
morphological changes with respect to control cells) [19].
3. Results
3.1. Antibacterial activity of the plant extracts
B. orellana methanolic extract in vitro antibacterial effect
was measured on S. mutans and S. sanguinis strains and inhi-
bition zones over 12 mm were considered positive. For
S. mutans the seed extract produced an inhibition zone of
15.11 mm and the leaves extract an inhibition zone of 19.97 mm.
Moreover, the Petri dishes with S. sanguinis showed an
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extract, respectively. In both bacterial cultures a larger inhibition
zone was observed in the leaves methanolic extracts (Table 1).Table 1
B. orellana methanolic extract in vitro antibacterial effect on S. mutans
and S. sanguinis strains. mm.
Micro
organism
Treatments Inhibition zone
Mean ± SD Median Minimum Maximum
S. mutans Seed extract 15.11 ± 1.03 14.78 14.02 17.11
Leaf extract 19.97 ± 1.31 19.82 17.92 22.08
Chlorhexidine 23.97 ± 1.75 23.41 21.12 27.82
S. sanguinis Seed extract 16.15 ± 2.15 15.78 13.76 19.18
Leaf extract 19.97 ± 1.26 19.71 18.84 23.16
Chlorhexidine 19.80 ± 1.18 19.70 18.00 21.803.2. MIC of B. orellana methanolic extract
The MIC of the B. orellana methanolic extract from seeds
and leaves were calculated for both S. mutans and S. sanguinis
strains. For S. mutans, we observed a MIC between 25 and
50 mg/mL for the seeds extract and a MIC between 50 and
75 mg/mL for the leaves extract. On the other hand, for the
S. sanguinis strains a MIC of 125 mg/mL was observed for the
seeds extract and a lower MIC between 50 and 75 mg/mL was
observed for the leaves extract (Table 2).Table 2
Determination of the MIC of the B. orellana methanolic extract in
S. mutans and S. sanguinis strains.
Extract concentration
(mg/mL)
S. mutans S. sanguinis
Leaves
extract
Seeds
extract
Leaves
extract
Seeds
extract
500.000 – – – –
250.000 – – – –
125.000 – – – MIC
62.500 MIC – MIC –
31.250 – MIC – –
15.625 – – – –3.3. Cytotoxicity of B. orellana extract
The cytotoxicity of the methanolic extracts of B. orellana
was determined using MDCK cells for virus propagation.
MDCK cells were incubated with increasing concentrations
(from 0 to 1 000 mg/mL) of B. orellana seeds and leaves ex-
tracts; cell viability was determined by MTT method. Relative
viability of MDCK cells was calculated by comparison with
untreated cultures (control, 0 mg/mL). Results indicated that the
B. orellana extract did not produce adverse effects on MDCK
cells cultures at low concentrations. However, the methanolic
extract from B. orellana leaves produced 50% cellular viability
inhibition with a concentration of 366.45 mg/mL, and the CC50
of seeds extract was 325.05 mg/mL. These values were
conﬁrmed by microscopic observation of the cytopathic effect.
4. Discussion
Phytotherapy has been used for the treatment of many
conditions, and its applications expand from the most simpleextract preparations introduced by natives, to the more com-
plex pharmacological processes to identify and obtain bioac-
tive substances that are commonly used in modern medicine
[18].
B. orellana antibacterial effect has been demonstrated in
many investigations [1]. Some of these studies have been done in
bacteria that can potentially be pathogenic in humans [20–22].
However, the information about the antibacterial effect of
B. orellana on oral bacteria is limited.
The human oral mucosa is colonized by a very wide bacterial
microbiota. S. mutans and S. sanguinis are important members
of the oral ﬂora. Although they live in homeostasis with other
oral bacteria, both of them have been also identiﬁed as potential
pathogens of dental caries and periodontal disease [23]. S. mutans
is the most important cause of dental caries and the viridans
group of streptococci (e.g. S. sanguinis) can cause bacteremia
and endocarditis [24].
The agar diffusion method showed that the B. orellana
methanolic extract presents antibacterial activity against
S. mutans and S. sanguinis strains. This method corroborates
that methanol is an effective organic solvent to extract phenols
and ﬂavonoids from plants just as Leyva et al. have previously
demonstrated [25]. Similar antibacterial properties have been
previously described in other bacterial strains [22,26]. The
inhibitory activity of seed extract of B. orellana could be
attributed to the presence of ﬂavonoids. Flavonoids have the
ability to assemble extracellular complexes with soluble
proteins and the bacterial cell wall. Alternatively, lipophilic
ﬂavonoids may also disrupt bacterial membranes [27].
Furthermore, the methanolic extract showed different MIC
for leaves and seeds. This could be related to the fact that the
active antibacterial principles obtained in the plant leaves and
seeds might be isolated in different concentrations, and greater
efﬁciency in leaf extract compared to seed extract may be due to
the absence of alkaloids in seeds.
The methanolic extract was proved to be cytotoxic for the
MDCK cells at high concentrations. The information from pre-
vious studies is not enough to compare the CC50 from their
extracts with our results. Nonetheless, a study in 2011 reported a
CC50 of 60.2 mg/mL for a seed hydro-alcoholic extract of
B. orellana [28]. This might indicate that the hydro-alcoholic
extracts can reach very low cytotoxic concentrations, whereas
methanolic extracts appear to be safe.
The achiote appears to be a non-toxic natural product with a
lot of potential uses in the odontology ﬁeld due to their anti-
bacterial properties against S. mutans and S. sanguinis. How-
ever, in Peru investigations regarding B. orellana and other
plants with potential medical uses are poor. Further studies are
needed to understand more about its antimicrobial applications,
as well as potential cytotoxic effects, adverse events, other drugs
interactions and contraindications.
The study results partially validate the B. orellana applica-
tions in the odontology ﬁeld, with antimicrobial properties and
a non-toxic proﬁle. This natural product may bring new alter-
natives for the antibiotic treatments used in oral infections. Our
results also highlight the importance of the ethnobotany prop-
erties evaluation in the selection of future possible bioactive
components. In this regard, our study wants to demonstrate the
great value of plants metabolites used in traditional medicine
and their possible applications in the development of new
medicines.
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